- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Depression Research and Treatment
Volume 2012 (2012), Article ID 628434, 5 pages
Direct Health Care Costs of Treating Seasonal Affective Disorder: A Comparison of Light Therapy and Fluoxetine
1Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5
2Department of Psychiatry, University of Toronto, Toronto, ON, Canada
3Centre for Addiction and Mental Health, Toronto, ON, Canada
4Department of Psychiatry, University of British Columbia, Canada
5School of Nursing, Ontario Training Centre in Health Services and Policy Research, McMaster University, Canada
6Department of Psychiatry, University of Manitoba, Canada
7Department of Psychiatry, Dalhousie University, Canada
Received 16 February 2012; Accepted 19 September 2012
Academic Editor: H. Grunze
Copyright © 2012 Amy Cheung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Washington, DC, 4th edition, 2000.
- J. M. Eagles, S. A. Naji, D. A. Gray, J. Christie, and J. A. G. Beattie, “Seasonal affective disorder among primary care consulters in January: Prevalence and month by month consultation patterns,” Journal of Affective Disorders, vol. 49, no. 1, pp. 1–8, 1998.
- J. M. Eagles, F. L. Howie, I. M. Cameron et al., “Use of health care services in seasonal affective disorder,” British Journal of Psychiatry, vol. 180, pp. 449–454, 2002.
- J. E. Andrew, S. M. Wileman, F. L. Howie, I. M. Cameron, S. A. Naji, and J. M. Eagles, “Comparison of consultation rates in primary care attenders with and without seasonal affective disorder,” Journal of Affective Disorders, vol. 62, no. 3, pp. 199–205, 2001.
- R. W. Lam, C. P. Gorman, M. Michalon et al., “Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder,” American Journal of Psychiatry, vol. 152, no. 12, pp. 1765–1770, 1995.
- M. Terman, J. S. Terman, and D. C. Ross, “A controlled trial of timed bright light and negative air ionization for treatment of winter depression,” Archives of General Psychiatry, vol. 55, no. 10, pp. 875–882, 1998.
- C. I. Eastman, M. A. Young, L. F. Fogg, L. Liu, and P. M. Meaden, “Bright light treatment of winter depression: a placebo-controlled trial,” Archives of General Psychiatry, vol. 55, no. 10, pp. 883–889, 1998.
- E. E. Michalak, G. Murray, A. J. Levitt et al., “Quality of life as an outcome indicator in patients with seasonal affective disorder: results from the Can-SAD study,” Psychological Medicine, vol. 37, no. 5, pp. 727–736, 2007.
- A. V. Ravindran, R. W. Lam, M. J. Filteau et al., “Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments,” Journal of Affective Disorders, vol. 117, no. 1, pp. S54–S64, 2009.
- American Psychiatric Association, “Practice guideline for the treatment of patients with major depressive disorder,” The American Journal of Psychiatry, vol. 157, pp. 1–45, 2000.
- I. M. Anderson, I. N. Ferrier, R. C. Baldwin et al., “Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines,” Journal of Psychopharmacology, vol. 22, no. 4, pp. 343–396, 2008.
- M. Bauer, P. C. Whybrow, J. Angst, M. Versiani, and H. J. Möller, “World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: acute and continuation treatment of major depressive disorder,” The World Journal of Biological Psychiatry, vol. 3, no. 1, pp. 5–43, 2002.
- R. W. Lam, A. J. Levitt, R. D. Levitan et al., “The can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder,” American Journal of Psychiatry, vol. 163, no. 5, pp. 805–812, 2006.
- G. Browne, A. Gafni, and J. Roberts, “The health and social service utilization survey,” System-Linked Research Unit, McMaster University, Hamilton, Canada, 2006.
- G. Browne, A. Gafni, and J. Roberts, “Approach to the measurement of costs (Expenditures) when evaluating health and social programmes,” System-Linked Research Unit, McMaster University, Hamilton, Canada, 2006.
- H. G. Birnbaum, R. Ben-Hamadi, P. E. Greenberg, M. Hsieh, J. Tang, and C. Reygrobellet, “Determinants of direct cost differences among US employees with major depressive disorders using antidepressants,” PharmacoEconomics, vol. 27, no. 6, pp. 507–517, 2009.
- M. H. Trivedi, A. J. Rush, S. R. Wisniewski et al., “Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice,” American Journal of Psychiatry, vol. 163, no. 1, pp. 28–40, 2006.
- A. Westrin and R. W. Lam, “Long-term and preventative treatment for seasonal affective disorder,” CNS Drugs, vol. 21, no. 11, pp. 901–909, 2007.
- D. J. F. Van Schaik, A. F. J. Klijn, H. P. J. Van Hout et al., “Patients' preferences in the treatment of depressive disorder in primary care,” General Hospital Psychiatry, vol. 26, no. 3, pp. 184–189, 2004.